Search Results

You are looking at 1 - 10 of 39 items for :

  • diabetic nephropathy x
  • Refine by Access: All content x
Clear All
Open access

Yiqiong Ma, Zhaowei Chen, Yu Tao, Jili Zhu, Hongxia Yang, Wei Liang, and Guohua Ding

Introduction As a severe type of diabetic microangiopathy, diabetic nephropathy (DN) is considered the most common cause of end-stage renal disease (ESRD) worldwide ( 1 ). In China, there are 113.9 million people with diabetes, and the

Open access

Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Rui Zhang, Jiali Wang, Yuancheng Zhao, Chunmei Qin, Huan Xu, Lin Li, Zhonglin Chai, Mark E Cooper, Nanwei Tong, and Fang Liu

Introduction It is well established that diabetic nephropathy (DN) is the first cause of end-stage renal disease (ESRD) in developed and developing countries ( 1 ). In China, both the incidence and prevalence of DN have risen dramatically over

Open access

Ram P Narayanan, Bo Fu, Adrian H Heald, Kirk W Siddals, Robert L Oliver, Julie E Hudson, Antony Payton, Simon G Anderson, Anne White, William E R Ollier, and J Martin Gibson

Introduction The rising prevalence of diabetes worldwide is associated with increased morbidity and mortality (1) . Diabetic nephropathy is a major complication of diabetes and is the commonest cause of end-stage renal disease (2) . The

Open access

Chunliang Yang, Junyi Li, Fei Sun, Haifeng Zhou, Jia Yang, and Chao Yang

Neurotoxicity Diabetic nephropathy Fuel the Na + reabsorption Secondary hypertension Trigger the production of profibrotic mediators Renal fibrosis Diabetic cardiomyopathy Accelerate Na + entry into myocytes Arrhythmia and heart

Open access

W Liu, Y Wang, X Han, X Cai, Y Zhu, M Zhang, S Gong, J Li, and L Ji

are the conventionally used predictors of diabetic retinopathy (DR) and diabetic nephropathy (DN). ( 2 , 3 ) Previous studies have shown that almost all T1DM patients are likely to develop some degree of DN within 20 years of diagnosis. ( 4 , 5 ) In

Open access

Yu Ah Hong, Kyung-Do Han, Jae-Seung Yun, Eun Sil Sil, Seung-Hyun Ko, and Sungjin Chung

Introduction Diabetic nephropathy is a major microvascular complication of type 2 diabetes mellitus (DM), and in many countries of the world, it is the major cause of end-stage renal disease (ESRD) ( 1 , 2 , 3 ). Identification of high

Open access

Espen Nordheim and Trond Geir Jenssen

. This review is based on literature search in Pubmed with the following combinations of keywords: 'diabetic nephropathy', 'diabetic kidney disease', 'diabetic nephropathy treatment' and 'diabetic kidney disease treatment' to complete our own bibliography

Open access

Xi Zhang, Xiurong Shen, Wan Zhou, Mengyun Xu, Yan Xing, Jianping Weng, Shandong Ye, Suowen Xu, Zhi Zhang, and Wei Wang

diabetic retinopathy, diabetic nephropathy, and cardiovascular diseases ( 5 , 6 , 7 , 8 , 9 ). For neurological diseases, the role of LCN2 has been implicated in diabetic encephalopathy and some other neurological diseases in animal models with

Open access

Guang-Ran Yang, Dongmei Li, and Zidian Xie

Singapore ( 10 ). Obesity is a risk factor of diabetic nephropathy ( 11 , 12 ). DR and diabetic nephropathy had common pathogenesis mechanisms. Currently, there is a lack of consensus on whether a high BMI increases the risk of DR. The ongoing Behavioral

Open access

Chun-feng Lu, Wang-shu Liu, Xiao-qin Ge, and Feng Xu

and retinopathy . Diabetes and Metabolic Syndrome 2018 12 1019 – 1024 . ( https://doi.org/10.1016/j.dsx.2018.06.017 ) 4 Zhang XX Kong J Yun K . Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a